Forst T - Search Results

1

The influence of isolated small nerve fibre dysfunction on microvascular control in patients with diabetes mellitus.

Pfützner A, Forst T, Engelbach M, Margin T, Goitom K, Löbig M, Beyer J, Kunt T. Pfützner A, et al. Among authors: forst t. Diabet Med. 2001 Jun;18(6):489-94. doi: 10.1046/j.1464-5491.2001.00524.x. Diabet Med. 2001. PMID: 11472469

2

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.

Langenfeld MR, Forst T, Hohberg C, Kann P, Lübben G, Konrad T, Füllert SD, Sachara C, Pfützner A. Langenfeld MR, et al. Among authors: forst t. Circulation. 2005 May 17;111(19):2525-31. doi: 10.1161/01.CIR.0000165072.01672.21. Epub 2005 May 9. Circulation. 2005. PMID: 15883215 Clinical Trial.

3

Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes.

Forst T, Uhlig-Laske B, Ring A, Graefe-Mody U, Friedrich C, Herbach K, Woerle HJ, Dugi KA. Forst T, et al. Diabet Med. 2010 Dec;27(12):1409-19. doi: 10.1111/j.1464-5491.2010.03131.x. Diabet Med. 2010. PMID: 21059094 Clinical Trial.

4

Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.

Pfützner J, Forst T, Butzer R, Forst S, Weber MM, Pfützner AH, Pfützner A. Pfützner J, et al. Among authors: forst s, forst t. Diabet Med. 2006 Oct;23(10):1124-9. doi: 10.1111/j.1464-5491.2006.01945.x. Diabet Med. 2006. PMID: 16978378

5

Early fasting glucose measurements can predict later glycaemic response to once weekly dulaglutide.

Grunberger G, Forst T, Fernández Landó L, Pechtner V, Shaginian R, Jia N, Gough S. Grunberger G, et al. Among authors: forst t. Diabet Med. 2016 Mar;33(3):391-4. doi: 10.1111/dme.12833. Epub 2015 Jul 21. Diabet Med. 2016. PMID: 26179454 Clinical Trial.

6

IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes.

Forst T, Standl E, Hohberg C, Konrad T, Schulze J, Strotmann HJ, Lübben G, Pahler S, Bachinger A, Langenfeld M, Pfützner A. Forst T, et al. Diabet Med. 2004 Oct;21(10):1149-53. doi: 10.1111/j.1464-5491.2004.01298.x. Diabet Med. 2004. PMID: 15384965

7

Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.

Pfützner A, Harzer O, Kunt T, Forst T, Abdollahnia N, Löbig M, Krauss H, Engelbach M, Kann P, Beyer J. Pfützner A, et al. Among authors: forst t. Clin Lab. 2000;46(5-6):275-9. Clin Lab. 2000. PMID: 10853236

8

Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitus.

Urban PP, Forst T, Lenfers M, Koehler J, Connemann BJ, Beyer J. Urban PP, et al. Among authors: forst t. Electromyogr Clin Neurophysiol. 1999 Jul-Aug;39(5):267-72. Electromyogr Clin Neurophysiol. 1999. PMID: 10421997

9

Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus.

Forst T, Pfützner A, Kann P, Schehler B, Lobmann R, Schäfer H, Andreas J, Bockisch A, Beyer J. Forst T, et al. Diabet Med. 1995 Oct;12(10):874-9. doi: 10.1111/j.1464-5491.1995.tb00389.x. Diabet Med. 1995. PMID: 8846677

10

Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.

Forst T, De La Tour DD, Kunt T, Pfützner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Löbig M, Engelbach M, Beyer J, Vague P. Forst T, et al. Clin Sci (Lond). 2000 Mar;98(3):283-90. Clin Sci (Lond). 2000. PMID: 10677386 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results